EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%

Cat. No.: X23-10-ZQ1057

EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%

Synonym: Falnidamol; 196612-93-8; BIBX 1382; BIBX1382; BIBX-1382; N8-(3-Chloro-4-fluorophenyl)-N2-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-2,8-diamine; EGFR-HER2 inhibitor

  • MDL: MFCD09838900
  • CAS Number: 196612-93-8
  • Compound CID: 6918508
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BIBX 1382 is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR and ErbB2.
Molecular Weight
460.8
Molecular Formula
C18H19ClFN7.2HCl
Targets
EGFR: 3 nM; ErbB2: 3.4 μM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BIBX 1382 can be used to inhibit EGFR tyrosine kinase for research into cancer therapy.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.